Updates on Molecular Pathogenesis of Non-Hodgkin’s Lymphoma
摘要
Recent advances in molecular characterization of different types of cancers improved refining the diagnostic criteria, prediction of prognosis, and identification of correct targets for drug development. Considering the board functional heterogenicity and property to transform in lymphoid malignancies, varied pathogenic mechanisms have been proposed underlying B cell, T cell, or lineage negative lymphomas. These current pieces of evidence show that although intrinsic genetic variations, epigenetic alterations, oncogenic viruses, and microenvironmental interactions are implicated in all subtypes of lymphomas, unique subtypes present accumulation for particular recurrent aberrations targeting specific pathways.